Corine Bertolotto

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 8

Top Topics

Staphylococcus Aureus

Signaling Pathway

Top Venues

Proceedings of the National Academy of Sciences of the United States of America

Pigment cell & melanoma research

Comptes rendus biologies

EMBO molecular medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Luca Di Leo, Chiara Pagliuca, Ali Kishk, Salvatore Rizza, Christina Tsiavou, Chiara Pecorari, Christina Dahl, Maria Pires Pacheco, Rikke Tholstrup, Jonathan Richard Brewer, Pietro Berico, Eva Hernando, Francesco Cecconi, Robert Ballotti, Corine Bertolotto, Giuseppe Filomeni, Morten Frier Gjerstorff, Thomas Sauter, Penny Lovat, Per Guldberg, Daniela De Zio
AMBRA1 levels predict resistance to MAPK inhibitors in melanoma. Proceedings of the National Academy of Sciences of the United States of America 121 (25) (2024)
Luca Di Leo, Chiara Pagliuca, Ali Kishk, Salvatore Rizza, Christina Tsiavou, Chiara Pecorari, Christina Dahl, Maria Pires Pacheco, Rikke Tholstrup, Jonathan Richard Brewer, Pietro Berico, Eva Hernando, Francesco Cecconi, Robert Ballotti, Corine Bertolotto, Giuseppe Filomeni, Morten Frier Gjerstorff, Thomas Sauter, Penny Lovat, Per Guldberg, Daniela De Zio
AMBRA1 levels predict resistance to MAPK inhibitors in melanoma. Proceedings of the National Academy of Sciences of the United States of America 121 (25) (2024)
Luca Di Leo, Chiara Pagliuca, Ali Kishk, Salvatore Rizza, Christina Tsiavou, Chiara Pecorari, Christina Dahl, Maria Pires Pacheco, Rikke Tholstrup, Jonathan Richard Brewer, Pietro Berico, Eva Hernando, Francesco Cecconi, Robert Ballotti, Corine Bertolotto, Giuseppe Filomeni, Morten Frier Gjerstorff, Thomas Sauter, Penny Lovat, Per Guldberg, Daniela De Zio
AMBRA1 levels predict resistance to MAPK inhibitors in melanoma. Proceedings of the National Academy of Sciences of the United States of America 121 (25) (2024)
Sarah Proteau, Imène Krossa, Chrystel Husser, Maxime Guéguinou, Federica Sella, Karine Bille, Marie Irondelle, Mélanie Dalmasso, Thibault Barouillet, Yann Cheli, Céline Pisibon, Nicole Arrighi, Sacha Nahon-Estève, Arnaud Martel, Lauris Gastaud, Sandra Lassalle, Olivier Mignen, Patrick Brest, Nathalie M Mazure, Frédéric Bost, Stéphanie Baillif, Solange Landreville, Simon Turcotte, Dan Hasson, Saul Carcamo, Christophe Vandier, Emily Bernstein, Laurent Yvan-Charvet, Mitchell Paul Levesque, Robert Ballotti, Corine Bertolotto, Thomas Strub
LKB1-SIK2 loss drives uveal melanoma proliferation and hypersensitivity to SLC8A1 and ROS inhibition. EMBO molecular medicine (2023)
Imène Krossa, Robert Ballotti, Corine Bertolotto
The ERK signaling pathway returns to the limelight in uveal melanomas. Pigment cell & melanoma research 34 (5) (2021)
Corine Bertolotto
Cutaneous and uveal melanoma: two different cancers in therapeutic needs. Comptes rendus biologies 344 (3) (2021)
Robert Ballotti, Yann Cheli, Corine Bertolotto
The complex relationship between MITF and the immune system: a Melanoma ImmunoTherapy (response) Factor? Molecular cancer 19 (1) (2020)
Robert Ballotti, Eugene Healy, Corine Bertolotto
Nicotinamide as a chemopreventive therapy of skin cancers. Too much of good thing? Pigment cell & melanoma research 32 (4) (2019)